Need help finding what you are looking for?
Contact Us
PUBLISHER: Transparency Market Research | PRODUCT CODE: 1110446
PUBLISHER: Transparency Market Research | PRODUCT CODE: 1110446
Ultra-large Volume Wearable Injectors Market (Indication: Diabetes, Autoimmune Diseases, Oncology, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
PUBLISHED:
PAGES: 144 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
The report provides revenue of the global ultra-large volume wearable injectors market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global ultra-large volume wearable injectors market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the ultra-large volume wearable injectors market.
The report delves into the competitive landscape of the global ultra-large volume wearable injectors market. Key players operating in the global ultra-large volume wearable injectors market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global ultra-large volume wearable injectors market profiled in this report.
Product Code: TMRGL78474
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Ultra-large Volume Wearable Injectors Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Indication Definition
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Ultra-large Volume Wearable Injectors Market Analysis and Forecast, 2017-2031
- 4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
- 5.1. Pipeline Analysis
- 5.2. Key Industry Developments
- 5.3. Ultra-large Volume Wearable Injectors Overview
- 5.4. COVID-19 Pandemics Impact on Industry
6. Global Ultra-large Volume Wearable Injectors Market Analysis and Forecast, by Indication
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Indication, 2017-2031
- 6.3.1. Diabetes
- 6.3.2. Autoimmune Diseases
- 6.3.3. Oncology
- 6.3.4. Others
- 6.4. Market Attractiveness, by Indication
7. Global Ultra-large Volume Wearable Injectors Market Analysis and Forecast, by Distribution Channel
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by Distribution Channel, 2017-2031
- 7.3.1. Retail Pharmacies & Drug stores
- 7.3.2. E-commerce
- 7.3.3. Others
- 7.4. Market Attractiveness, by Distribution Channel
8. Global Ultra-large Volume Wearable Injectors Market Analysis and Forecast, by Region
- 8.1. Key Findings
- 8.2. Market Value Forecast, by Region
- 8.2.1. North America
- 8.2.2. Europe
- 8.2.3. Asia Pacific
- 8.2.4. Latin America
- 8.2.5. Middle East & Africa
- 8.3. Market Attractiveness, by Region
9. North America Ultra-large Volume Wearable Injectors Market Analysis and Forecast
- 9.1. Introduction
- 9.1.1. Key Findings
- 9.2. Market Value Forecast, by Indication, 2017-2031
- 9.2.1. Diabetes
- 9.2.2. Autoimmune Diseases
- 9.2.3. Oncology
- 9.2.4. Others
- 9.3. Market Value Forecast, by Distribution Channel, 2017-2031
- 9.3.1. Retail Pharmacies & Drug stores
- 9.3.2. E-commerce
- 9.3.3. Others
- 9.4. Market Value Forecast, by Country, 2017-2031
- 9.4.1. U.S.
- 9.4.2. Canada
- 9.5. Market Attractiveness Analysis
- 9.5.1. By Indication
- 9.5.2. By Distribution Channel
- 9.5.3. By Country
10. Europe Ultra-large Volume Wearable Injectors Market Analysis and Forecast
- 10.1. Introduction
- 10.1.1. Key Findings
- 10.2. Market Value Forecast, by Indication, 2017-2031
- 10.2.1. Diabetes
- 10.2.2. Autoimmune Diseases
- 10.2.3. Oncology
- 10.2.4. Others
- 10.3. Market Value Forecast, by Distribution Channel, 2017-2031
- 10.3.1. Retail Pharmacies & Drug stores
- 10.3.2. E-commerce
- 10.3.3. Others
- 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
- 10.4.1. Germany
- 10.4.2. U.K.
- 10.4.3. France
- 10.4.4. Italy
- 10.4.5. Spain
- 10.4.6. Rest of Europe
- 10.5. Market Attractiveness Analysis
- 10.5.1. By Indication
- 10.5.2. By Distribution Channel
- 10.5.3. By Country/Sub-region
11. Asia Pacific Ultra-large Volume Wearable Injectors Market Analysis and Forecast
- 11.1. Introduction
- 11.1.1. Key Findings
- 11.2. Market Value Forecast, by Indication, 2017-2031
- 11.2.1. Diabetes
- 11.2.2. Autoimmune Diseases
- 11.2.3. Oncology
- 11.2.4. Others
- 11.3. Market Value Forecast, by Distribution Channel, 2017-2031
- 11.3.1. Retail Pharmacies & Drug stores
- 11.3.2. E-commerce
- 11.3.3. Others
- 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.4.1. China
- 11.4.2. Japan
- 11.4.3. India
- 11.4.4. Australia & New Zealand
- 11.4.5. Rest of Asia Pacific
- 11.5. Market Attractiveness Analysis
- 11.5.1. By Indication
- 11.5.2. By Distribution Channel
- 11.5.3. By Country/Sub-region
12. Latin America Ultra-large Volume Wearable Injectors Market Analysis and Forecast
- 12.1. Introduction
- 12.1.1. Key Findings
- 12.2. Market Value Forecast, by Indication, 2017-2031
- 12.2.1. Diabetes
- 12.2.2. Autoimmune Diseases
- 12.2.3. Oncology
- 12.2.4. Others
- 12.3. Market Value Forecast, by Distribution Channel, 2017-2031
- 12.3.1. Retail Pharmacies & Drug stores
- 12.3.2. E-commerce
- 12.3.3. Others
- 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.4.1. Brazil
- 12.4.2. Mexico
- 12.4.3. Rest of Latin America
- 12.5. Market Attractiveness Analysis
- 12.5.1. By Indication
- 12.5.2. By Distribution Channel
- 12.5.3. By Country/Sub-region
13. Middle East & Africa Ultra-large Volume Wearable Injectors Market Analysis and Forecast
. Introduction
- 13.1.1. Key Findings
- 13.2. Market Value Forecast, by Indication, 2017-2031
- 13.2.1. Diabetes
- 13.2.2. Autoimmune Diseases
- 13.2.3. Oncology
- 13.2.4. Others
- 13.3. Market Value Forecast, by Distribution Channel, 2017-2031
- 13.3.1. Retail Pharmacies & Drug stores
- 13.3.2. E-commerce
- 13.3.3. Others
- 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.4.1. GCC Countries
- 13.4.2. South Africa
- 13.4.3. Rest of Middle East & Africa
- 13.5. Market Attractiveness Analysis
- 13.5.1. By Indication
- 13.5.2. By Distribution Channel
- 13.5.3. By Country/Sub-region
14. Competition Landscape
- 14.1. Market Player - Competition Matrix (By Tier and Size of companies)
- 14.2. Company Profiles
- 14.2.1. Becton, Dickinson and Company
- 14.2.1.1. Company Overview
- 14.2.1.2. Financial Overview
- 14.2.1.3. Product Portfolio
- 14.2.1.4. SWOT Analysis
- 14.2.1.5. Strategic Overview
- 14.2.2. Buhler Motor GmbH
- 14.2.2.1. Company Overview
- 14.2.2.2. Financial Overview
- 14.2.2.3. Product Portfolio
- 14.2.2.4. SWOT Analysis
- 14.2.2.5. Strategic Overview
- 14.2.3. West Pharmaceutical Services, Inc.
- 14.2.3.1. Company Overview
- 14.2.3.2. Financial Overview
- 14.2.3.3. Product Portfolio
- 14.2.3.4. SWOT Analysis
- 14.2.3.5. Strategic Overview
- 14.2.4. Ypsomed AG
- 14.2.4.1. Company Overview
- 14.2.4.2. Financial Overview
- 14.2.4.3. Product Portfolio
- 14.2.4.4. SWOT Analysis
- 14.2.4.5. Strategic Overview
- 14.2.5. Medtronic
- 14.2.5.1. Company Overview
- 14.2.5.2. Financial Overview
- 14.2.5.3. Product Portfolio
- 14.2.5.4. SWOT Analysis
- 14.2.5.5. Strategic Overview
- 14.2.6. Sonceboz
- 14.2.6.1. Company Overview
- 14.2.6.2. Financial Overview
- 14.2.6.3. Product Portfolio
- 14.2.6.4. SWOT Analysis
- 14.2.6.5. Strategic Overview
- 14.2.7. Enable Injections
- 14.2.7.1. Company Overview
- 14.2.7.2. Financial Overview
- 14.2.7.3. Product Portfolio
- 14.2.7.4. SWOT Analysis
- 14.2.7.5. Strategic Overview
- 14.2.8. Subcuject Aps
- 14.2.8.1. Company Overview
- 14.2.8.2. Financial Overview
- 14.2.8.3. Product Portfolio
- 14.2.8.4. SWOT Analysis
- 14.2.8.5. Strategic Overview
- 14.2.9. Nemera
- 14.2.9.1. Company Overview
- 14.2.9.2. Financial Overview
- 14.2.9.3. Product Portfolio
- 14.2.9.4. SWOT Analysis
- 14.2.9.5. Strategic Overview
- 14.2.10. Eitan Medical
- 14.2.10.1. Company Overview
- 14.2.10.2. Financial Overview
- 14.2.10.3. Product Portfolio
- 14.2.10.4. SWOT Analysis
- 14.2.10.5. Strategic Overview
- 14.2.11. Weibel CDS AG
- 14.2.11.1. Company Overview
- 14.2.11.2. Financial Overview
- 14.2.11.3. Product Portfolio
- 14.2.11.4. SWOT Analysis
- 14.2.11.5. Strategic Overview
- 14.2.12. Gerresheimer AG
- 14.2.12.1. Company Overview
- 14.2.12.2. Financial Overview
- 14.2.12.3. Product Portfolio
- 14.2.12.4. SWOT Analysis
- 14.2.12.5. Strategic Overview
- 14.2.1. Becton, Dickinson and Company
Product Code: TMRGL78474
List of Tables
- Table 01: Global Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Indication, 2017-2031
- Table 02: Global Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
- Table 03: Global Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Region, 2017-2031
- Table 04: North America Continence Care Market Value (US$ Bn) Forecast, by Country, 2017-2031
- Table 05: North America Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Indication, 2017-2031
- Table 06: North America Ultra-large Volume Wearable Injectors Market (US$ Bn) Forecast, by Distribution Channel, 2017-2031
- Table 07: Europe Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Country/Sub-Region, 2017-2031
- Table 08: Europe Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Indication, 2017-2031
- Table 09: Europe Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
- Table 10: Asia Pacific Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Country/Sub-Region, 2017-2031
- Table 11: Asia Pacific Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Indication, 2017-2031
- Table 12: Asia Pacific Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
- Table 13: Latin America Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Country/Sub-Region, 2017-2031
- Table 14: Latin America Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Indication, 2017-2031
- Table 15: Latin America Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
- Table 16: Middle East & Africa Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Country/Sub-Region, 2017-2031
- Table 17: Middle East & Africa Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Indication, 2017-2031
- Table 18: Middle East & Africa Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
List of Figures
- Figure 01: Global Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, 2017-2031
- Figure 02: Global Ultra-large Volume Wearable Injectors Market Value Share, by Indication, 2021
- Figure 03: Global Ultra-large Volume Wearable Injectors Market Value Share, by Distribution Channel, 2021
- Figure 04: Global Ultra-large Volume Wearable Injectors Market Value Share, by Region, 2021
- Figure 05: Global Ultra-large Volume Wearable Injectors Market, by Indication, 2021 and 2031
- Figure 06: Global Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Indication, 2021-2031
- Figure 07: Global Ultra-large Volume Wearable Injectors Market (US$ Bn), by Diabetes, 2017-2031
- Figure 08: Global Ultra-large Volume Wearable Injectors Market (US$ Bn), by Autoimmune Diseases, 2017-2031
- Figure 09: Global Ultra-large Volume Wearable Injectors Market (US$ Bn), by Oncology, 2017-2031
- Figure 10: Global Ultra-large Volume Wearable Injectors Market (US$ Bn), by Others, 2017-2031
- Figure 11: Global Ultra-large Volume Wearable Injectors Market, by Distribution Channel, 2021 and 2031
- Figure 12: Global Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Distribution Channel, 2021-2031
- Figure 13: Global Ultra-large Volume Wearable Injectors Market (US$ Bn), by Retail Pharmacies & Drug stores, 2017-2031
- Figure 14: Global Ultra-large Volume Wearable Injectors Market (US$ Bn), by E-commerce, 2017-2031
- Figure 15: Global Ultra-large Volume Wearable Injectors Market (US$ Bn), by Others, 2017-2031
- Figure 16: Global Ultra-large Volume Wearable Injectors Market Value Share Analysis, by Region, 2021 and 2031
- Figure 17: Global Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Region, 2022-2031
- Figure 18: North America Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, 2017-2031
- Figure 19: North America Ultra-large Volume Wearable Injectors Market Value Share Analysis, by Country, 2021 and 2031
- Figure 20: North America Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Country, 2022-2031
- Figure 21: North America Ultra-large Volume Wearable Injectors Market, by Indication, 2020 and 2031
- Figure 22: North America Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Indication, 2022-2031
- Figure 23: North America Ultra-large Volume Wearable Injectors Market, by Indication, 2020 and 2031
- Figure 24: North America Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Indication, 2021-2031
- Figure 25: Europe Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, 2017-2031
- Figure 26: Europe Ultra-large Volume Wearable Injectors Market Value Share Analysis, by Country/Sub-Region, 2021 and 2031
- Figure 27: Europe Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
- Figure 28: Europe Ultra-large Volume Wearable Injectors Market, by Indication, 2020 and 2031
- Figure 29: Europe Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Indication, 2022-2031
- Figure 30: Europe Ultra-large Volume Wearable Injectors Market, by Distribution Channel, 2021 and 2031
- Figure 31: Europe Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Distribution Channel, 2022-2031
- Figure 32: Asia Pacific Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, 2017-2031
- Figure 33: Asia Pacific Ultra-large Volume Wearable Injectors Market Value Share Analysis, by Country/Sub-Region, 2021 and 2031
- Figure 34: Asia Pacific Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
- Figure 35: Asia Pacific Ultra-large Volume Wearable Injectors Market, by Indication, 2021 and 2031
- Figure 36: Asia Pacific Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Indication, 2022-2031
- Figure 37: Asia Pacific Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Distribution Channel, 2022-2031
- Figure 38: Asia Pacific Ultra-large Volume Wearable Injectors Market, by Distribution Channel, 2021 and 2031
- Figure 39: Latin America Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, 2017-2031
- Figure 40: Latin America Ultra-large Volume Wearable Injectors Market Value Share Analysis, by Country/Sub-Region, 2021 and 2031
- Figure 41: Latin America Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
- Figure 42: Latin America Ultra-large Volume Wearable Injectors Market, by Indication, 2021 and 2031
- Figure 43: Latin America Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Indication, 2022-2031
- Figure 44: Latin America Ultra-large Volume Wearable Injectors Market, by Distribution Channel, 2021 and 2031
- Figure 45: Latin America Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Distribution Channel, 2022-2031
- Figure 46: Middle East & Africa Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, 2017-2031
- Figure 47: Middle East & Africa Ultra-large Volume Wearable Injectors Market Value Share Analysis, by Country/Sub-Region, 2021 and 2031
- Figure 48: Middle East & Africa Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
- Figure 49: Middle East & Africa Ultra-large Volume Wearable Injectors Market, by Indication, 2021 and 2031
- Figure 50: Middle East & Africa Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Indication, 2022-2031
- Figure 51: Middle East & Africa Ultra-large Volume Wearable Injectors Market, by Distribution Channel, 2021 and 2031
- Figure 52: Middle East & Africa Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Distribution Channel, 2022-2031
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.